Braxia Scientific Corp
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery metho… Read more
Braxia Scientific Corp (BRAXF) - Total Assets
Latest total assets as of December 2023: $2.34 Million USD
Based on the latest financial reports, Braxia Scientific Corp (BRAXF) holds total assets worth $2.34 Million USD as of December 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Braxia Scientific Corp - Total Assets Trend (2020–2023)
This chart illustrates how Braxia Scientific Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Braxia Scientific Corp - Asset Composition Analysis
Current Asset Composition (March 2023)
Braxia Scientific Corp's total assets of $2.34 Million consist of 55.5% current assets and 44.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 37.7% |
| Accounts Receivable | $408.93K | 10.5% |
| Inventory | $8.68K | 0.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $868.06K | 22.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2023)
This chart illustrates how Braxia Scientific Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Braxia Scientific Corp's current assets represent 55.5% of total assets in 2023, an increase from 15.6% in 2020.
- Cash Position: Cash and equivalents constituted 37.7% of total assets in 2023, up from 10.8% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, a decrease from 133.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 22.4% of total assets.
Braxia Scientific Corp Competitors by Total Assets
Key competitors of Braxia Scientific Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Braxia Scientific Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Braxia Scientific Corp generates 0.49x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Braxia Scientific Corp is currently not profitable relative to its asset base.
Braxia Scientific Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.18 | 1.54 | 14.85 |
| Quick Ratio | 0.22 | 1.54 | 13.10 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.81 Million | $ 715.82K | $ 843.79K |
Braxia Scientific Corp - Advanced Valuation Insights
This section examines the relationship between Braxia Scientific Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.82 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -66.6% |
| Total Assets | $3.88 Million |
| Market Capitalization | $30.02K USD |
Valuation Analysis
Below Book Valuation: The market values Braxia Scientific Corp's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Braxia Scientific Corp's assets decreased by 66.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Braxia Scientific Corp (2020–2023)
The table below shows the annual total assets of Braxia Scientific Corp from 2020 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-03-31 | $3.88 Million | -66.62% |
| 2022-03-31 | $11.63 Million | -37.08% |
| 2021-03-31 | $18.49 Million | +31.43% |
| 2020-03-31 | $14.07 Million | -- |